Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
NHL supported by an Immunohistochemical report
Eastern Cooperative Oncology Group (ECOG) performance status greater than or equal to (\>/=) 2
Total serum bilirubin less than (\<) 2 times upper limit of normal (ULN)
Absolute neutrophil count (ANC) greater than (\>) 2 x10\^9 per liter (/L)
You may not be if
Bone marrow compromised \> 10 percent (%)
Any malignant myeloid condition
Active infections requiring systemic anti-infectious therapies (antibiotics, antifungal drugs, antiviral drugs) within 72 hours prior to CT or ICT initiation
Known hypersensitivity reactions to Escherichia coli derived products
Pregnant or nursing participants. Women with childbearing potential should use a safe contraceptive method
Clareo Health | An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL)
